KNSA FY 2018 Earnings — Kiniksa Pharmaceuticals, Ltd. Revenue & Financial Results | Market Cap Arena

KNSAKiniksa Pharmaceuticals, Ltd.

$3B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$286,000

Operating Income

-$108M

Net Income

-$103M

EPS (Diluted)

$-3.49

Cash Flow

Operating Cash Flow

-$81M

Free Cash Flow

-$86M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$322M

Total Liabilities

$43M

Stockholders' Equity

-$194M

Cash & Equivalents

$307M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$286,000	-$28,000	-921.4%
Operating Income	-$108M	-$65M	-65.4%
Net Income	-$103M	-$65M	-59.1%